Canada’s Knight Therapeutics and Brazil’s Eurofarma have reportedly presented offers to buy the Brazilian pharmaceutical company
Category: Capital Markets
Posted inDaily Brief
Vivara prices IPO near top of range
Brazilian jewelry retailer aims to raise around $500m from its stock market debut
Posted inDaily Brief
IDB targets Japanese investors with next sustainable bonds
DC-based development bank could carry out a private placement before the end of the year, according to the head of funding
Posted inDaily Brief
A3 schedules local bond debut
Chilean hotel operator plans to sell notes as low interest rates boost deal activity for refinancing debt, sources say
Posted inDaily Brief
Rutas 2 and 7 launches bond sale
Toll road concessionaire sets the yield on $458m in cross-border notes at 5%, sources say
Posted inDaily Brief
Promigas prices cross-border debut
Colombian natural gas company issues $400m in 10-year bonds at 230bp over US Treasury notes
Posted inDaily Brief
Pei hires bookrunner for local notes
Colombian real estate recruits Davivienda to arrange a $145m debt sale by the end of the year
Posted inDaily Brief
Bondholders bypass Codelco buyback
Investors tender $130m in 2022 and 2023 notes, short of the Chilean copper miner’s target of $639m
Posted inDaily Brief
Peru’s Contugas closes loan deal
Peruvian natural gas company secures five-year $335 mln loan with nine lenders
Posted inDaily Brief
Bradesco contemplates extraordinary dividends
Brazilian bank’s executive team submits proposal for $1.95bn in extraordinary dividends to shareholders